ID
43789
Description
An Extension Study to Assess the Safety, Tolerability and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's Disease and Persistent Motor-Complications Despite Optimized Treatment With Available Anti-Parkinsonian Medications; ODM derived from: https://clinicaltrials.gov/show/NCT02082249
Lien
https://clinicaltrials.gov/show/NCT02082249
Mots-clés
Versions (2)
- 01/05/2016 01/05/2016 -
- 20/09/2021 20/09/2021 -
Téléchargé le
20 septembre 2021
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Advanced Parkinson's Disease NCT02082249
Eligibility Advanced Parkinson's Disease NCT02082249
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
subject is enrolled in another clinical trial
Type de données
boolean
Alias
- UMLS CUI [1]
- C2348568
Description
interfere with patient
Type de données
boolean
Alias
- UMLS CUI [1]
- C0525058
- UMLS CUI [2]
- C0525058
- UMLS CUI [3]
- C0004936
Description
contraindication to continued levodopa therapy
Type de données
boolean
Alias
- UMLS CUI [1]
- C1301624
- UMLS CUI [2]
- C0023570
Description
Patient Non-Compliance
Type de données
boolean
Alias
- UMLS CUI [1]
- C0376405
Description
suicidal ideation
Type de données
boolean
Alias
- UMLS CUI [1]
- C0424000
Description
unsuitable candidate to continue to receive
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C3839545
- UMLS CUI [1,2]
- C2002915
Similar models
Eligibility Advanced Parkinson's Disease NCT02082249
- StudyEvent: Eligibility
C0525058 (UMLS CUI [2])
C0004936 (UMLS CUI [3])
C0023570 (UMLS CUI [2])
C2002915 (UMLS CUI [1,2])